Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Qili dispersing tablet for treating traumatic injuries, and its prepn. method

A technology for dispersible tablets and bruises, applied in the field of Jieda qili dispersible tablets and their preparation, can solve problems such as inconvenience in taking, inaccurate dose distribution, and achieve the effects of improving quality standards, improving product quality, and ensuring drug demand.

Inactive Publication Date: 2004-10-20
毛友昌
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The powder has a quick effect, but the dosage is inaccurate, and it is inconvenient to take. The tablet overcomes the inaccurate dosage, but the disintegration is slow, while the dispersible tablet overcomes the above shortcomings, and has the advantages of convenient administration, rapid onset, and accurate dosage. Advantages, and its quality standard can be further improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] The best embodiment of the present invention is: the ten flavors in the prescription are tested and qualified respectively for subsequent use; musk and borneol are ground into fine powder respectively, cinnabar is pulverized into fine powder, Radix Notoginseng is pulverized into fine powder, and all the other six flavors are pulverized into fine powder; Mix cinnabar, panax notoginseng powder and appropriate amount of auxiliary materials, granulate, dry, add musk, fine powder of borneol and appropriate amount of auxiliary materials, mix evenly, and compress into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A Chinese medicine 'injury Qili dispersable tablet' for treating the bone fracture, injury and traumatic hemorrhage is an improvement to existing same medicine in the form of tablet or powder. Its advantages are correct dosage, high curative effect and high safety.

Description

technical field [0001] The invention relates to the technical field of manufacturing technology of Chinese patent medicine dispersible tablets, in particular to Dieda Qili dispersible tablets and a preparation method thereof. Background technique [0002] Dispersible tablets are a commonly used drug dosage form. According to the relevant drug laws and regulations of our country, changing the dosage form should be regarded as a new drug research. The original dosage forms of Dieda Qili Dispersible Tablets are: Dieda Qili Tablets, Dieda Qili Powder, which have been listed It has been included in the National Standards Compilation of Chinese Patent Medicines of the State Food and Drug Administration (Trial Standards of Landmark Upgrade to National Standards). The technical characteristics of the original tablet are: the cinnabar water in the prescription is flying into a very fine powder, the musk, dried blood, and borneol are respectively ground into fi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61P7/04A61P19/00A61P29/00
Inventor 毛友昌毛晓敏
Owner 毛友昌
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products